October 29, 2023

Infringement by Experimentation: the Demarcation Line

David Gilat, Partner, Head of Legal Practice
David Gilat

Partner, Head of Legal Practice

Gilat, Bareket & Co.

This article was included in the AIPPI Congress News and explains the significance of the AIPPI Resolution on “Experimental Use and Bolar-type Exemptions to Patent Infringement,”, which plays an important role in pursuing global and lasting healthcare for everyone.

Click here to read

This article is provided for general information only. It is not intended as legal advice or opinion and cannot be relied upon as such. Advice on specific matters may be provided by our group’s attorneys.

Contact Us
Newsletter Sign Up